BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22927248)

  • 1. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome.
    Xu J; Wang D; Liu D; Fan Z; Zhang H; Liu O; Ding G; Gao R; Zhang C; Ding Y; Bromberg JS; Chen W; Sun L; Wang S
    Blood; 2012 Oct; 120(15):3142-51. PubMed ID: 22927248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease.
    Khalili S; Liu Y; Kornete M; Roescher N; Kodama S; Peterson A; Piccirillo CA; Tran SD
    PLoS One; 2012; 7(6):e38615. PubMed ID: 22685592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
    Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
    Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis.
    Yao G; Qi J; Liang J; Shi B; Chen W; Li W; Tang X; Wang D; Lu L; Chen W; Shi S; Hou Y; Sun L
    Theranostics; 2019; 9(26):8253-8265. PubMed ID: 31754394
    [No Abstract]   [Full Text] [Related]  

  • 5. Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells.
    Shi B; Qi J; Yao G; Feng R; Zhang Z; Wang D; Chen C; Tang X; Lu L; Chen W; Sun L
    Stem Cell Res Ther; 2018 Nov; 9(1):308. PubMed ID: 30409219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity.
    Zou Y; Xiao W; Liu D; Li X; Li L; Peng L; Xiong Y; Gan H; Ren X
    Immun Inflamm Dis; 2024 Jan; 12(1):e1139. PubMed ID: 38270310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
    Wang SQ; Wang YX; Hua H
    Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells.
    Li B; Xing Y; Gan Y; He J; Hua H
    Stem Cell Res Ther; 2021 Aug; 12(1):478. PubMed ID: 34446113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren's syndrome by modulating the function of myeloid-derived suppressor cells.
    Rui K; Hong Y; Zhu Q; Shi X; Xiao F; Fu H; Yin Q; Xing Y; Wu X; Kong X; Xu H; Tian J; Wang S; Lu L
    Cell Mol Immunol; 2021 Feb; 18(2):440-451. PubMed ID: 33408339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
    Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI
    Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.
    Barr JY; Wang X; Meyerholz DK; Lieberman SM
    Immunol Cell Biol; 2017 Sep; 95(8):684-694. PubMed ID: 28465508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice.
    Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
    Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
    Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
    Zheng X; Wang Q; Yuan X; Zhou Y; Chu H; Wang G; Li X; Wang Y; Wei L; Wang L; Li X
    J Immunol Res; 2020; 2020():4896727. PubMed ID: 33062721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells  from exfoliated  deciduous  teeth alleviate hyposalivation caused by Sjögren syndrome.
    Du ZH; Ding C; Zhang Q; Zhang Y; Ge XY; Li SL; Yu GY
    Oral Dis; 2019 Sep; 25(6):1530-1544. PubMed ID: 31046162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
    Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
    Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome.
    Tian J; Hong Y; Zhu Q; Zhou H; Zhang Y; Shen Z; Guo H; Zhang Y; Ai X; Zhao F; Rui K; Xu H; Wang S
    Front Immunol; 2020; 11():604607. PubMed ID: 33414787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
    Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
    Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
    Lieberman SM; Kreiger PA; Koretzky GA
    Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compact Bone-Derived Multipotent Mesenchymal Stromal Cells (MSCs) for the Treatment of Sjogren's-like Disease in NOD Mice.
    Elghanam GA; Liu Y; Khalili S; Fang D; Tran SD
    Methods Mol Biol; 2017; 1553():25-39. PubMed ID: 28229405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.